ChromaDex banner

Margaretta Colangelo


Managing Editor Margaretta Colangelo is a native San Franciscan with over 30 years of experience working in the software industry in Silicon Valley. She has been at the forefront of emerging technologies throughout her entire career and has a deep and multifaceted understanding of business, science, and technology, and is highly adept at tracking and forecasting innovation in technology.

Margaretta serves on the advisory boards of the AI Precision Health Institute at the University of Hawaii Cancer Center, Ageing Research at King's (ARK-AI) at King's College London, NaNotics, First Longevity, Robots Go Mental, and on the Board of Directors of the Bring Hope Humanitarian Foundation.




Promising restorative therapy potentially 5 years away

Oisín Biotech on targeting senescence and senolytic gene therapy.   “The ultimate goal is to eliminate unnecessary suffering. I think that everyone who believes in the mission...

New Buck Institute research is big news for Longevity

New research from The Buck Institute has big implications for chronic diseases of aging. The new research from The Buck Institute for Research on Aging,...

Nanoparticles to strip away senescent cell defences

For thousands of years, doctors and indigenous healers have treated disease by adding molecules to people’s bodies in the form of pharmaceuticals, herbs and...

Longevity companies to watch in 2021

As the world enters the new year with a vaccine and an increased focus on geroprotection, there’s much to look forward to. Research from the...